000 01294 a2200385 4500
005 20250516072708.0
264 0 _c20120604
008 201206s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/138161212799040510
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLymperopoulos, Anastasios
245 0 0 _aGRK2 inhibition in heart failure: something old, something new.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2012
300 _a186-91 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenal Glands
_xmetabolism
650 0 4 _aAdrenergic beta-Antagonists
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aChronic Disease
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug Design
650 0 4 _aG-Protein-Coupled Receptor Kinase 2
_xantagonists & inhibitors
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aRabbits
650 0 4 _aSignal Transduction
650 0 4 _aSwine
650 0 4 _aUp-Regulation
700 1 _aRengo, Giuseppe
700 1 _aKoch, Walter J
773 0 _tCurrent pharmaceutical design
_gvol. 18
_gno. 2
_gp. 186-91
856 4 0 _uhttps://doi.org/10.2174/138161212799040510
_zAvailable from publisher's website
999 _c21446647
_d21446647